Table II.
Outcome | Intervention n/N (%) |
Control n/N (%) |
Prevalence Risk Ratio (95% CI) |
p value |
---|---|---|---|---|
In HIV carea | 178/194 (92%) | 167/199 (84%) | 1.09 (1.00–1.19) | 0.039 |
On ARTb | 71/194 (37%) | 71/199 (36%) | 1.03 (0.78–1.34) | 0.85 |
On cotrimoxazolec | 173/194 (89%) | 161/199 (81%) | 1.10 (1.00–1.21) | 0.047 |
Own bednet | 131/194 (68%) | 135/199 (68%) | 1.00 (0.84–1.18) | 0.96 |
Bednet adherentd | 91/194 (47%) | 94/199 (47%) | 0.99 (0.79–1.25) | 0.95 |
Own water vessel | 74/194 (38%) | 49/199 (25%) | 1.55 (1.09–2.20) | 0.014 |
Water vessel adherente | 45/194 (23%) | 28/199 (14%) | 1.64 (1.07–2.55) | 0.024 |
Basic care package adherentf | 31/194 (16%) | 18/199 (9%) | 1.77 (1.04–3.00) | 0.035 |
Any sex past 12 months | 170/194 (88%) | 174/199 (87%) | 1.00 (0.90–1.11) | 0.97 |
Multiple sexual partnersg | 61/170 (35%) | 51/174 (29%) | 1.22 (0.89–1.68) | 0.21 |
Any condom useh | 107/170 (63%) | 102/174 (59%) | 1.07 (0.86–1.34) | 0.53 |
Currently? Yes/No;
Currently? Yes/No;
Currently? Yes/No;
Always Use vs Other;
Always Use vs. Other;
On cotrimoxazole and bednet adherent and water vessel adherent vs. Other;
>1 Partner vs. 1 Partner, among sexually active only;
Any condom use past 12 months vs. Other, among sexually active only.